Facebook   Instagram   LinkedIn
icone
Cadastre-se para receber novidades e promoções da FAREX

VIVIRAM-V

VIVIRAM-V

Analeptic and respiratory stimulant

DESCRIPCIÓN

Solution for injection: doxapram-based respiratory stimulant (analeptic).

PRESENTACIÓN

Bottle per 10 ml.

ACCIÓN

Analeptic. Cardiac and pulmonary stimulant through carotid chemoreceptors. The respiratory center at CNS level is stimulated with higher doses. 

INDICACIONES

In animals with ventilatory depression due to barbiturates, buprenorphine, xylazine and inhaled agents. It accelerates post-anesthesia recovery. It stimulates start of breathing in depressed newborns. To measure circulation time in horses.  

FÓRMULA

100 mL of solution contains:
Doxapram hydrochloride 2 g.
Excipients q.s.

POSOLOGÍA Y ADMINISTRACIÓN

Equines: 0.5 mg/kg (equivalent to 2.5 mL every 100 kg of weight) IV. This dose can be repeated after 15-20 min.
Canine - Feline: Depression due to inhalation anesthesia: 1 mg/kg IV; due to barbiturates, xylazine and buprenorphine: 5 to 10 mg/kg IV.
Newborns: 1 to 2 drops of the solution by injection, sublingual, by umbilical vein or subcutaneous route.

CONTRAINDICACIONES

Do not administer to animals with seizure-causing illnesses, heart failure or pneumothorax. Do not administer to pregnant females.

EFECTOS COLATERALES

Doxapram causes an uninterrupted increase in heart rate during the first minute after administration, as well as abnormalities in the magnitude and polarity of the T wave visible in the ECG. Both effects are transitory and are not enhanced by a second administration of the product.

RESTRICCIONES DE USO

Do not use in pregnant females.

PRECAUCIÓN

Use with caution in patients with a history of respiratory diseases, arrhythmias or tachycardia. Do not administer more than 2 times with a 15-20 minute interval. It is essential for administration that the animal’s airways are not obstructed.